Paper39713612
Magnetic Nanocarriers for pH/GSH/NIR Triple-Responsive Drug Release and Synergistic Therapy in Tumor Cells.
Zhang D and 8 others. ACS Omega, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Magnetic Nanocarriers for pH/GSH/NIR Triple-Responsive Drug Release and Synergistic Therapy in Tumor Cells. Papers, record 39713612. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39713612
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Magnetic Nanocarriers for pH/GSH/NIR Triple-Responsive Drug Release and Synergistic Therapy in Tumor Cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36812969 | Synthesis of chitosan succinate-g-amine functionalized mesoporous silica: Inorganic-organic nanohybrid for antibacterial assessment, antioxidant activity and pH-controlled drug delivery. | Int J Biol Macromol | 2023 | https://conductscience.org/library/papers/36812969 | PubMed |
| 2 | 35642539 | Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? | Chem Soc Rev | 2022 | https://conductscience.org/library/papers/35642539 | PubMed |
| 3 | 32254406 | A dual-responsive, hyaluronic acid targeted drug delivery system based on hollow mesoporous silica nanoparticles for cancer therapy. | J Mater Chem B | 2018 | https://conductscience.org/library/papers/32254406 | PubMed |
| 4 | 36414398 | Multifunctional Superparticles for Magnetically Targeted NIR-II Imaging and Photodynamic Therapy. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/36414398 | PubMed |
| 5 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 6 | 35798082 | Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles. | Int J Biol Macromol | 2022 | https://conductscience.org/library/papers/35798082 | PubMed |
| 7 | 36632234 | Nanomaterial-based CT contrast agents and their applications in image-guided therapy. | Theranostics | 2023 | https://conductscience.org/library/papers/36632234 | PubMed |
| 8 | 36944197 | Synthesis of Monodispersed Hollow Mesoporous Organosilica and Silica Nanoparticles with Controllable Shell Thickness Using Soft and Hard Templates. | Langmuir | 2023 | https://conductscience.org/library/papers/36944197 | PubMed |
| 9 | 35259519 | TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy. | Acta Biomater | 2022 | https://conductscience.org/library/papers/35259519 | PubMed |
| 10 | 28274115 | Progress in Nanotheranostics Based on Mesoporous Silica Nanomaterial Platforms. | ACS Appl Mater Interfaces | 2017 | https://conductscience.org/library/papers/28274115 | PubMed |
| 11 | 34738816 | Intelligent Pore Switch of Hollow Mesoporous Organosilica Nanoparticles for High Contrast Magnetic Resonance Imaging and Tumor-Specific Chemotherapy. | Nano Lett | 2021 | https://conductscience.org/library/papers/34738816 | PubMed |
| 12 | 35025274 | Label-Free Fluorescent Mesoporous Bioglass for Drug Delivery, Optical Triple-Mode Imaging, and Photothermal/Photodynamic Synergistic Cancer Therapy. | ACS Appl Bio Mater | 2020 | https://conductscience.org/library/papers/35025274 | PubMed |
| 13 | 35944586 | Multifunctional plasmonic-magnetic nanoparticles for bioimaging and hyperthermia. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/35944586 | PubMed |
| 14 | 36874010 | Nanoparticle drug delivery systems for synergistic delivery of tumor therapy. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36874010 | PubMed |
| 15 | 37137353 | Lutein-loaded chitosan/alginate-coated Fe3O4 nanoparticles as effective targeted carriers for breast cancer treatment. | Int J Biol Macromol | 2023 | https://conductscience.org/library/papers/37137353 | PubMed |
| 16 | 31761234 | ZnO capped flower-like porous carbon-Fe3O4 composite as carrier for bi-triggered drug delivery. | Mater Sci Eng C Mater Biol Appl | 2020 | https://conductscience.org/library/papers/31761234 | PubMed |
| 17 | 36703527 | Magnetic Targeting Nanocarriers Combined with Focusing Ultrasound for Enhanced Intracerebral Hemorrhage Therapy. | Small | 2023 | https://conductscience.org/library/papers/36703527 | PubMed |
| 18 | 30539634 | Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity. | ACS Appl Mater Interfaces | 2019 | https://conductscience.org/library/papers/30539634 | PubMed |
| 19 | 32797715 | Targeted Theranostic Nano Vehicle Endorsed with Self-Destruction and Immunostimulatory Features to Circumvent Drug Resistance and Wipe-Out Tumor Reinitiating Cancer Stem Cells. | Small | 2020 | https://conductscience.org/library/papers/32797715 | PubMed |
| 20 | 32739773 | SiO2-coated magnetic nano-Fe3O4 photosensitizer for synergistic tumour-targeted chemo-photothermal therapy. | Colloids Surf B Biointerfaces | 2020 | https://conductscience.org/library/papers/32739773 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978988 | Magnetic nanoplatforms at the tumor redox interface: from catalytic ROS amplification to ferroptosis and multimodal cancer therapy. | Front Oncol | 2026 | https://conductscience.org/library/papers/42978988 | PubMed |
| 42662568 | Mechanisms and therapeutic design of stimuli-responsive vesicular nanocarriers for melanoma. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42662568 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39713612
GET https://conductscience.org/api/papers/v1/39713612/references?page=2